Margaret Mulligan
2009
In 2009, Margaret Mulligan earned a total compensation of $1.8M as Executive Vice, President, Chief Financial Officer at Valeant Pharmaceuticals International, a 413% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $248,792 |
|---|---|
| Option Awards | $68,250 |
| Salary | $415,214 |
| Stock Awards | $1,049,938 |
| Total | $1,782,194 |
Mulligan received $1M in stock awards, accounting for 59% of the total pay in 2009.
Mulligan also received $248.8K in non-equity incentive plan, $68.3K in option awards and $415.2K in salary.
Rankings
In 2009, Margaret Mulligan's compensation ranked 2,695th out of 9,885 executives tracked by ExecPay. In other words, Mulligan earned more than 72.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,695 out of 9,885 | 73rd |
Division Manufacturing | 942 out of 3,690 | 75th |
Major group Chemicals And Allied Products | 183 out of 866 | 79th |
Industry group Drugs | 110 out of 638 | 83rd |
Industry Pharmaceutical Preparations | 87 out of 446 | 81st |
Source: SEC filing on April 14, 2011.
Mulligan's colleagues
We found six more compensation records of executives who worked with Margaret Mulligan at Valeant Pharmaceuticals International in 2009.
2009
William Wells
Valeant Pharmaceuticals International
Chief Executive Officer
2009
William Wells
Valeant Pharmaceuticals International
Chief Executive Officer
2009
Gilbert Godin
Valeant Pharmaceuticals International
Chief Operating Officer
2009
Christian Fibiger
Valeant Pharmaceuticals International
Chief Scientific Officer
2009
Gregory Gubitz
Valeant Pharmaceuticals International
General Counsel
2009
Mark Durham
Valeant Pharmaceuticals International